NCT02520336

Brief Summary

Assess postpartum diabetes screening in GDM patients with initiation of a reminder system in the postpartum period

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 7, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 11, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Last Updated

August 11, 2015

Status Verified

August 1, 2015

Enrollment Period

1 year

First QC Date

August 7, 2015

Last Update Submit

August 7, 2015

Conditions

Diabetes, Gestational

Outcome Measures

Primary Outcomes (1)

  • Postpartum Diabetes screening in GDM patients

    1 year

Study Arms (2)

active management

EXPERIMENTAL

Laboratoy test request given postpartum with phone reminder prior to test

Behavioral: Reminder

Routine care

NO INTERVENTION

Interventions

ReminderBEHAVIORAL
active management

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107, United States

RECRUITING

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2015

First Posted

August 11, 2015

Study Start

July 1, 2015

Primary Completion

July 1, 2016

Last Updated

August 11, 2015

Record last verified: 2015-08

Locations

US(1)